Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,707
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: Detroit MI, Ypsilanti MI, Lansing MI, Chicago IL,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
for
Aortic Stenosis Treated With TAVI, Aortic Diseases
Location: Detroit MI, Cleveland OH, Indianappolis IN, New York NY,
Sponsor: EnCompass Technologies, Inc.
Sex: All
Age: 50+
Code: NCT06689839
Recruiting
Active & Responsive
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Detroit MI, Cleveland OH, Fairfax VA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07111520
Phase1, Phase2, Recruiting
Active & Responsive
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
for
Type 1 Diabetes
Location: Detroit MI, Chicago IL, New York NY, Atlanta GA,
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT07676565
Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Detroit MI, Cleveland OH, Pittsburgh PA,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
for
Huntington Disease
Location: Detroit MI, Cleveland OH, Grand Rapids MI, North York,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 21 - 70
Code: NCT07326709
Phase3, Recruiting
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Detroit MI, Chicago IL, Washington D.C. DC, St Louis MO,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase1, Phase2, Recruiting
Active & Responsive
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
for
Relapsing Multiple Sclerosis,
Location: Detroit MI, Cleveland OH, Evanston IL, Milwaukee WI,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT04047628
Phase3, Recruiting
Active & Responsive
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Location: Detroit MI, Cleveland OH, Columbus OH, Evanston IL,
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT01915511
Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Detroit MI, Ann Arbor MI, Grand Rapids MI, Columbus OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
for
Pressure Ulcer, Stage IV, Osteomyelitis
Location: Detroit MI, Pittsburgh PA, Chicago IL, Newark NJ,
Sponsor: Biocomposites Ltd
Sex: All
Age: 18+
Code: NCT06283979
Phase2, Recruiting
Active & Responsive
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
for
COPD, Chronic Obstructive Pulmonary Disease
Location: Detroit MI, Columbus OH, DuBois PA, Philadelphia PA,
Sponsor: Nuvaira, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07051707
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for
Rheumatoid Arthritis
Location: Detroit MI, Columbus OH, Glendale WI, Willowbrook IL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07137598
Phase2, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII